|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Non-cash finance expense (income) | |||||
| Non-cash interest expense | |||||
| Non-cash interest income | |||||
| Non- cash lease expense | |||||
| Non-cash goodwill impairment | |||||
| Deferred income tax | |||||
| Depreciation and amortization | |||||
| Depreciation and amortization expense | |||||
| Inventory write off | |||||
| Credit loss expense | |||||
| Impairment of long-lived assets | |||||
| Unrealized foreign currency exchange loss | |||||
| Loss on financial instruments, net | |||||
| Unrealized foreign currency exchange (gain) loss | |||||
| Gain on deconsolidation of wholly-owned subsidiary | |||||
| Change in deferred revenue | |||||
| Non-cash government assistance | |||||
| Gain on sale of property, plant and equipment | |||||
| Loss on debt settlement | |||||
| Gain on sale of Next Bridge Notes Receivable | |||||
| Stock-based compensation expense and other non-cash personnel expense (recovery) | |||||
| Stock-based compensation and other non-cash personnel expense (recovery) | |||||
| Non-cash consulting expense | |||||
| Changes in operating assets and liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of intangible assets | |||||
| Purchases of property, plant and equipment | |||||
| Proceeds from sale of property, plant and equipment | |||||
| Proceeds from (Purchases of) short-term investments | |||||
| Proceeds from short-term investments | |||||
| Proceeds from below-market capital government loan | |||||
| Purchase of short-term investments | |||||
| Proceeds from collection of Next Bridge Notes Receivable | |||||
| Acquisition of business, net of cash acquired | |||||
| Proceeds from sale of Next Bridge Notes Receivable | |||||
| Loan advance pursuant to deconsolidation | |||||
| Proceeds from reverse takeover | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from long-term debt | |||||
| Proceeds from the issuance of common stock and warrants | |||||
| Stock issuance costs paid on the issuance of common stock and warrants | |||||
| Repayments of long-term debt | |||||
| Proceeds from government grants | |||||
| Proceeds from unsecured promissory notes | |||||
| Proceeds from stock option exercises | |||||
| Proceeds from stock option and warrants exercises | |||||
| Repurchases of common stock for income tax withheld upon settlement of restricted stock units | |||||
| Proceeds from warrant exercises | |||||
| Net cash provided by financing activities | |||||
| Cash - beginning of period | |||||
| Cash - end of period | |||||
| Cash - beginning of year | |||||
| Net decrease in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of the year | |||||
| Effects of exchange rate changes on cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at end of the year | |||||
| Supplemental cash flow information | |||||
| Subscription receivable for sale of common stock | |||||
| Accrued purchases of property, equipment, and patents | |||||
| Right-of-use assets obtained in exchange for lease liabilities | |||||
| Right-of-use assets and prepaid expenses recognized in exchange for common stock | |||||
| Settlement of liabilities in common stock | |||||
| Interest paid on debt | |||||
| Common stock issuance costs in accrued liabilities or accounts payable | |||||
| Deemed dividends on warrants upon trigger of downround feature | |||||
| Non-cash issuance costs as a result of amendment of June 2022 warrants | |||||
Loading...